MAGNANI, CHIARA FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.092
AS - Asia 1.902
EU - Europa 1.846
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 52
OC - Oceania 6
Totale 9.364
Nazione #
US - Stati Uniti d'America 4.795
SG - Singapore 664
IT - Italia 527
CN - Cina 401
VN - Vietnam 262
HK - Hong Kong 247
DE - Germania 232
CA - Canada 224
RU - Federazione Russa 205
BR - Brasile 200
SE - Svezia 196
IE - Irlanda 154
GB - Regno Unito 119
FR - Francia 85
UA - Ucraina 83
BD - Bangladesh 61
IN - India 52
FI - Finlandia 43
NL - Olanda 36
PL - Polonia 35
ES - Italia 34
TR - Turchia 27
AR - Argentina 26
ID - Indonesia 24
PK - Pakistan 24
BE - Belgio 22
KR - Corea 20
ZA - Sudafrica 20
CH - Svizzera 19
DK - Danimarca 19
JP - Giappone 18
MX - Messico 17
IQ - Iraq 16
PH - Filippine 14
SA - Arabia Saudita 14
VE - Venezuela 14
HN - Honduras 12
CO - Colombia 9
EC - Ecuador 9
TN - Tunisia 9
SV - El Salvador 8
UZ - Uzbekistan 8
AT - Austria 7
JM - Giamaica 7
NP - Nepal 7
MY - Malesia 6
TT - Trinidad e Tobago 6
CL - Cile 5
EU - Europa 5
KE - Kenya 5
MA - Marocco 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
GP - Guadalupe 4
IL - Israele 4
PY - Paraguay 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
MK - Macedonia 3
NI - Nicaragua 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
UY - Uruguay 3
AD - Andorra 2
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
BZ - Belize 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
Totale 9.173
Città #
Ashburn 539
Ann Arbor 475
Singapore 338
Woodbridge 270
Chandler 244
San Jose 242
Fairfield 236
Hong Kong 236
Houston 213
Wilmington 161
Milan 157
Frankfurt am Main 149
Dublin 147
Council Bluffs 133
Toronto 125
Cambridge 102
Seattle 99
Dearborn 92
Jacksonville 91
Santa Clara 90
New York 86
Ho Chi Minh City 85
Los Angeles 69
Chicago 62
Dallas 59
Hanoi 53
Princeton 51
Beijing 50
The Dalles 45
Nanjing 43
Rome 42
Shanghai 35
Buffalo 32
Hefei 32
Montreal 32
Lauterbourg 26
Boardman 25
Lissone 25
North Bergen 25
Brooklyn 23
Denver 23
São Paulo 23
Lawrence 22
Brussels 21
Kraków 18
Lachine 16
Phoenix 16
Altamura 15
Helsinki 15
Seoul 15
Stockholm 15
Warsaw 15
Zurich 15
Da Nang 14
Munich 14
Nanchang 14
Washington 14
Johannesburg 13
Tokyo 13
London 12
Orem 12
Amsterdam 11
Columbus 11
Jakarta 11
Moscow 11
San Francisco 11
Fremont 10
Genoa 9
Hangzhou 9
Jiaxing 9
Manchester 9
Poplar 9
San Diego 9
Tampa 9
Dong Ket 8
Haiphong 8
Hải Dương 8
Jinan 8
Pavia 8
Salt Lake City 8
Tashkent 8
Turku 8
Andover 7
Atlanta 7
Belo Horizonte 7
Bergamo 7
Brescia 7
Detroit 7
Dhaka 7
Edmonton 7
Florence 7
Guangzhou 7
Hebei 7
Jeddah 7
Queens 7
Shenyang 7
Zhengzhou 7
Ankara 6
Baghdad 6
Boston 6
Totale 5.689
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 519
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 468
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 458
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 429
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 397
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 386
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 382
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 382
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 368
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 349
Type 1 regulatory T cells: cytotoxic activity and molecular signature 332
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 328
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells 326
Donor-derived CD19-targeted T cells in allogeneic transplants 319
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 314
Acquired glucose sensitivity of k-ras transformed fibroblasts 311
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 304
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 303
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 294
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 274
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells 271
The Past, Present, and Future of Non-Viral CAR T Cells 265
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells 264
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway 256
Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations 245
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells 236
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 233
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 221
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 130
Totale 9.364
Categoria #
all - tutte 27.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022260 0 0 0 0 32 22 13 17 32 42 29 73
2022/2023772 89 220 102 69 40 110 9 42 58 4 23 6
2023/2024474 13 16 28 41 48 94 93 39 33 14 13 42
2024/20251.040 56 94 46 41 88 32 74 30 136 160 91 192
2025/20263.107 355 142 204 370 429 190 424 115 237 237 181 223
2026/20271.136 98 131 284 450 173 0 0 0 0 0 0 0
Totale 9.364